Jiangsu Recbio Technology's (HKG:2179) board approved the proposed conversion of 141,953,490 unlisted shares into H shares, a Wednesday Hong Kong bourse filing said.
Conversion will take place after the company obtains all necessary approvals.
Following completion, the company will have a total of 458,092,179 H shares in issue, making up 94.85% of its total share capital.
The firm will apply to the Hong Kong Stock Exchange to list and deal in the converted H shares.